Multicenter phase II trial of modified FOLFIRINOX in gemcitabine-refractory pancreatic cancer.
Chung MJ, Kang H, Kim HG, Hyun JJ, Lee JK, Lee KH, Noh MH, Kang DH, Lee SH, Bang S; Pancreatobiliary Cancer Study Group of Korean Society of Gastrointestinal Cancer.
Chung MJ, et al. Among authors: hyun jj.
World J Gastrointest Oncol. 2018 Dec 15;10(12):505-515. doi: 10.4251/wjgo.v10.i12.505.
World J Gastrointest Oncol. 2018.
PMID: 30595804
Free PMC article.